Skip to content
Brand AI

Laurus Labs

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2022

    Boehringer Ingelheim sues Laurus over Jardiance patent

    Lawsuit filed

    Boehringer Ingelheim Pharmaceuticals and related entities filed a lawsuit against Laurus Labs and Laurus Generics in Delaware, alleging patent infringement related to a generic version of Jardiance and seeking injunctive relief and monetary damages.

    Source excerpt

    • The plaintiff is suing for patent infringement and seeks declaratory judgment of infringement as well as injunctive relief preventing further infringement and monetary damages.
    • On Friday a case was filed in the District of Delaware by Boehringer Ingelheim Pharmaceuticals Inc., and related entities against Laurus Labs LTD and Laurus Generics Inc. The case is regarding patent infringement for the drug Jardiance.
    • Merck is seeking declaratory judgement of patent infringement after the defendants submitted an Abbreviated New Drug Application (ANDA) to the Food and Drug Administration (FDA) to produce a generic version of the plaintiff’s diabetes treatment.
    Source